Can manipulate the cascades from Receptor Tyrosine Kinase receptors to be used as a therapeutic agent.
If we block the ligand from binding to its specific receptors, we can stop the outcome of a particular ligand.
\
e.g, since cancer cells produce VEGF to stimulate greater blood flow to the tumour (in order to provide it with nutrients) if we block the VEGF binding site, we can prevent the cascade and stop tumour growth- by cutting off nutrient supply.
We could either use inhibitors or monoclonal antibodies as the blocking site hence the ligand can no longer bind.
Or we could use a drug which directly inhibits the activity of the enzymes in the cascade.